Your browser doesn't support javascript.
loading
Impact of hospital characteristics on implementation of a Pediatric Early Warning System in resource-limited cancer hospitals.
Abutineh, Farris; Graetz, Dylan E; Muniz-Talavera, Hilmarie; Ferrara, Gia; Puerto-Torres, Maria; Chen, Yichen; Gillipelli, Srinithya R; Elish, Paul; Gonzalez-Ruiz, Alejandra; Alfonso Carreras, Yvania; Alvarez, Shillel; Arce Cabrera, Daniela; Arguello Vargas, Deiby; Armenta Cruz, Miriam; Barra, Camila; Calderon Sotelo, Patricia; Carpio, Zulma; Chavez Rios, Mayra; Covarrubias, Daniela; de Leon Vasquez, Lucy; Diaz Coronado, Rosdali; Fing Soto, Ever Amilcar; Gomez-Garcia, Wendy; Hernandez, Cinthia; Juarez Tobias, María Susana; Leon, Esmeralda; Loeza Oliva, Jose de Jesus; Mendez, Alejandra; Miller, Kenia; Montalvo Cozar, Erika; Negroe Ocampo, Natalia Del Carmen; Penafiel, Eulalia; Pineda, Estuardo; Rios, Ligia; Rodriguez Ordonez, Esperanza; Soto Chavez, Veronica; Devidas, Meenakshi; Agulnik, Asya.
Afiliação
  • Abutineh F; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Graetz DE; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Muniz-Talavera H; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Ferrara G; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Puerto-Torres M; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Chen Y; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Gillipelli SR; Baylor College of Medicine, Houston, TX, United States.
  • Elish P; Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  • Gonzalez-Ruiz A; Abt Associates, Rockville, MD, United States.
  • Alfonso Carreras Y; Pediatric Oncology, Hospital Saint-Damien, Port-au-Prince, Haiti.
  • Alvarez S; Pediatric Oncology, Benemérito Hospital General con Especialidades "Juan María de Salvatierr", La Paz, Mexico.
  • Arce Cabrera D; Pediatric Hemato-Oncology Unit, Hospital Pediatrico de Sinaloa, Culiacan, Mexico.
  • Arguello Vargas D; Hemato-Oncology, Hospital Nacional de Niños, San Jose, Costa Rica.
  • Armenta Cruz M; Pediatric Oncology, Hospital General de Tijuana, Tijuana, Mexico.
  • Barra C; Pediatric Oncology, Centro de Investigacion Bradford Hill, Santiago, Chile.
  • Calderon Sotelo P; Pediatric Oncology, Hospital Infantil Manuel Rivera La Mascota, Managua, Nicaragua.
  • Carpio Z; Pediatric Oncology, Instituto Nacional de Enfermedades Neoplasticas, Lima, Peru.
  • Chavez Rios M; Hemato-Oncology, Hospital para el Niño Poblano, Puebla, Mexico.
  • Covarrubias D; Pediatric Oncology, Centro Estatal de Oncología de Campeche, Campeche, Mexico.
  • de Leon Vasquez L; Pediatric Oncology, Hospital Infantil Regional Universitario Dr. Arturo Grullon, Santiago, Dominican Republic.
  • Diaz Coronado R; Pediatric Oncology, Instituto Nacional de Enfermedades Neoplasticas, Lima, Peru.
  • Fing Soto EA; Pediatric Oncology, Hospital General Celaya, Celaya, Mexico.
  • Gomez-Garcia W; Oncology Unit, Hospital Infantil Dr. Robert Reid Cabral, Santo, Domingo, Dominican Republic.
  • Hernandez C; Nursing, Hospital Infantil Teletón de Oncología, Queretaro, Mexico.
  • Juarez Tobias MS; Pediatric, Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, Mexico.
  • Leon E; Medical Oncology, Hospital Guillermo Almenara Irigoyen, Lima, Peru.
  • Loeza Oliva JJ; Pediatric Oncology, Centro Estatal de Cancerologia, Xalapa, Mexico.
  • Mendez A; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Miller K; Pediatric Hemato-Oncology, Hospital del Niño "Jose Renan Esquivel", Panama City, Panama.
  • Montalvo Cozar E; Pediatric Intensive Care Unit, Hospital Oncológico Solca Núcleo de Quito, Quito, Ecuador.
  • Negroe Ocampo NDC; Pediatric Hemato-Oncology, Hospital General Agustin O'Horan, Merida, Mexico.
  • Penafiel E; Pediatric Oncology, Instituto del Cáncer SOLCA Cuenca, Cuenca, Ecuador.
  • Pineda E; Pediatric Hemato-Oncology, Hospital Nacional de Niños Benjamín Bloom, San Salvador, El Salvador.
  • Rios L; Pediatric Hemato-Oncology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.
  • Rodriguez Ordonez E; Pediatric Oncology, Centro Medico Nacional Siglo XXI, Mexico City, Mexico.
  • Soto Chavez V; Pediatric Hemato-Oncology, Hospital Civil de Guadalajara, Guadalajara, Mexico.
  • Devidas M; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Agulnik A; Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN, United States.
Front Oncol ; 13: 1122355, 2023.
Article em En | MEDLINE | ID: mdl-37207162
ABSTRACT

Background:

Pediatric Early Warning Systems (PEWS) aid in identification of deterioration in hospitalized children with cancer but are underutilized in resource-limited settings. Proyecto EVAT is a multicenter quality improvement (QI) collaborative in Latin America to implement PEWS. This study investigates the relationship between hospital characteristics and time required for PEWS implementation.

Methods:

This convergent mixed-methods study included 23 Proyecto EVAT childhood cancer centers; 5 hospitals representing quick and slow implementers were selected for qualitative analysis. Semi-structured interviews were conducted with 71 stakeholders involved in PEWS implementation. Interviews were recorded, transcribed and translated to English, then coded using a priori and novel codes. Thematic content analysis explored the impact of hospital characteristics and QI experience on time required for PEWS implementation and was supplemented by quantitative analysis exploring the relationship between hospital characteristics and implementation time.

Results:

In both quantitative and qualitative analysis, material and human resources to support PEWS significantly impacted time to implementation. Lack of resources produced various obstacles that extended time necessary for centers to achieve successful implementation. Hospital characteristics, such as funding structure and type, influenced PEWS implementation time by determining their resource-availability. Prior hospital or implementation leader experience with QI, however, helped facilitate implementation by assisting implementers predict and overcome resource-related challenges.

Conclusions:

Hospital characteristics impact time required to implement PEWS in resource-limited childhood cancer centers; however, prior QI experience helps anticipate and adapt to resource challenges and more quickly implement PEWS. QI training should be a component of strategies to scale-up use of evidence-based interventions like PEWS in resource-limited settings.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article